AXEPIM 0.5 g, powder for solution for injection bottle, 0.961 g
Active ingredients: Cefepime, Cefepime hydrochloride hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottle, 0.961 gintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AXEPIM 0,5 g, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 0,961 g
- Marketing authorisation holder
- BRISTOL MYERS SQUIBB
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Dec 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67461944CIP73702292CIP133400937022927Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFÉPIMEpoudre | 0,500 g · un flacon de 0,961 g | FT |
| CÉFÉPIME (DICHLORHYDRATE DE) MONOHYDRATÉpoudre | 0,601 g · un flacon de 0,961 g | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.